Cibus, Inc.
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Craig Wichner
- Full Time Employees
- 118
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 6455 Nancy Ridge Drive San Diego CA United States of America 92121
- IPO Date
- Jul 20, 2017
- CIK
- 0001705843
- Website
- cibus.com
- Similar Companies
- Business
- Cibus, Inc. is an agricultural technology firm focused on developing and licensing advanced plant traits to seed companies, generating revenue through royalties. The company primarily enhances crop productivity through its proprietary gene-editing platform, enabling farmers to achieve superior yields while minimizing the necessity for chemical crop protection and fertilizers. Additionally, Cibus develops sustainable ingredients and biofragrance solutions, empowering corporations to substitute fossil fuel-derived components or those contributing to increased greenhouse gas emissions. Based in San Diego, California, the company targets key global row crops like rice, canola, soybean, and alfalfa, expanding its intellectual property and commercial reach through recent partnerships in Latin America and Asia.
Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates
Cibus Q2 Earnings Call Highlights
Cibus Reports Second Quarter Financial Results and Provides Business Update
Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
Cibus Q1 Earnings Call Highlights
Cibus Reports First Quarter Financial Results and Provides Business Update
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
Cibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference Call
Cibus Announces the Election of Thomas Urban to Board of Directors
Cibus, Inc. Investigated by the Portnoy Law Firm
Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
Cibus (CBUS) Reports Q4 Loss, Lags Revenue Estimates